KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) Gross Margin (2016 - 2025)

Historic Gross Margin for Resmed (RMD) over the last 17 years, with Q4 2025 value amounting to 61.76%.

  • Resmed's Gross Margin rose 31600.0% to 61.76% in Q4 2025 from the same period last year, while for Dec 2025 it was 60.87%, marking a year-over-year increase of 24800.0%. This contributed to the annual value of 59.36% for FY2025, which is 26900.0% up from last year.
  • As of Q4 2025, Resmed's Gross Margin stood at 61.76%, which was up 31600.0% from 61.46% recorded in Q3 2025.
  • Resmed's Gross Margin's 5-year high stood at 61.76% during Q4 2025, with a 5-year trough of 54.44% in Q3 2023.
  • Over the past 5 years, Resmed's median Gross Margin value was 57.02% (recorded in 2022), while the average stood at 57.54%.
  • As far as peak fluctuations go, Resmed's Gross Margin plummeted by -24700bps in 2023, and later soared by 41400bps in 2024.
  • Over the past 5 years, Resmed's Gross Margin (Quarter) stood at 56.36% in 2021, then dropped by 0bps to 56.08% in 2022, then fell by -1bps to 55.64% in 2023, then increased by 5bps to 58.6% in 2024, then grew by 5bps to 61.76% in 2025.
  • Its Gross Margin stands at 61.76% for Q4 2025, versus 61.46% for Q3 2025 and 60.84% for Q2 2025.